ClassID:

21647

A61K2300/00 - page 37 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#10801
20100260904
2010-10-14

FIBER SATIETY COMPOSITIONS

#10802
20100260893
2010-10-14

Composition comprising polyunsaturated fatty acids and activated charcoal

#10803
20100260870
2010-10-14

METHOD AND PREPARATIONS FOR TREATING INFECTION-ALLERGIC DISEASES

#10804
20100260868
2010-10-14

Method of treatment using checkpoint kinase 1 inhibitors

#10805
20100260867
2010-10-14

Methods and compositions for the prevention and treatment of inflammatory diseases

#10806
20100260864
2010-10-14

Treatment or prevention of cancer and precancerous disorders

#10807
20100260857
2010-10-14

Enzyme delivery systems and methods of preparation and use

#10808
20100260841
2010-10-14

Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions

#10809
20100260836
2010-10-14

Kits for nutrition supplementation

#10810
20100260834
2010-10-14

Abuse-deterrent drug formulations

#10811
20100260833
2010-10-14

ABUSE-PROOFED DOSAGE FORM

#10812
20100260832
2010-10-14

COMBINATION THERAPY FOR OVARIAN CANCER

#10813
20100260831
2010-10-14

NON-PEGYLATED LIPOSOMAL DOXORUBICIN TRIPLE COMBINATION THERAPY

#10814
20100260828
2010-10-14

Modulation of platelet aggregation

#10815
20100260784
2010-10-14

PAI-1 BINDING MODULATORS FOR THE TREATMENT OF OCULAR DISORDERS

#10816
20100260781
2010-10-14

Treatment methods for autoimmune disorders

#10817
20100260776
2010-10-14

THERAPEUTIC METHOD FOR REDUCING ANGIOGENESIS

#10818
20100260767
2010-10-14

Composition and Method for Treating Inflammatory Disorders

#10819
20100260757
2010-10-14

USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY

#10820
20100260755
2010-10-14

IBUDILAST AND IMMUNOMODULATORS COMBINATION

#10821
20100260753
2010-10-14

AMINOFLAVONE (NSC 686288) AND COMBINATIONS THEREOF FOR TREATING BREAST CANCER

#10822
20100260737
2010-10-14

COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT

#10823
20100260733
2010-10-14

Anti aging agents and methods to identify them

#10824
20100260732
2010-10-14

ROLE FOR SRY IN PARKINSON'S DISEASE

#10825
20100260723
2010-10-14

IMPLANTABLE SYSTEM FOR AN INTERVERTEBRAL DISC AND INTERVERTEBRAL DISC IMPLANT

#10826
20100260720
2010-10-14

Prevention of opportunistic infections in immune-compromised subjects

#10827
20100260719
2010-10-14

Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione

#10828
20100260717
2010-10-14

Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection

#10829
20100260715
2010-10-14

Hepatitis C virus inhibitors

#10830
20100260713
2010-10-14

Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs

#10831
20100260712
2010-10-14

USE OF HUMAN ANTIBODY CAPABLE OF NEUTRALIZING HEPATITIS B VIRUS FOR THE PREVENTION OR TREATMENT OF HEPATITIS B VIRUS INFECTION

#10832
20100260692
2010-10-14

MOUTHWASH COMPOSITION COMPRISING XANTHAN GUM AND SODIUM FLUORIDE

#10833
20100260680
2010-10-14

NOVEL BONE MASS INCREASING AGENT

#10834
20100260678
2010-10-14

ANTI-IGF-I RECEPTOR ANTIBODIES

#10835
20100256241
2010-10-07

Method for treating atypical facial pain

#10836
20100256237
2010-10-07

Potentiating the effect of compound comprising nitric oxide

#10837
20100256230
2010-10-07

1-BUTANE ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND THE USE THEREOF

#10838
20100256224
2010-10-07

Angiogenesis inhibitor

#10839
20100256193
2010-10-07

Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof

#10840
20100256191
2010-10-07

AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR EPILEPSY

#10841
20100256093
2010-10-07

Methods of and compositions for reducing cell death

#10842
20100256092
2010-10-07

BORON-CONTAINING SMALL MOLECULES

#10843
20100256089
2010-10-07

Unique combinations of antimicrobial compositions

#10844
20100256083
2010-10-07

ORGAN PROTECTION, PRESERVATION AND RECOVERY

#10845
20100256076
2010-10-07

Compositions and methods related to calcitriol

#10846
20100256066
2010-10-07

ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS

#10847
20100255538
2010-10-07

Antibodies to insulin-like growth factor I receptor

#10848
20100255156
2010-10-07

Edible mix and method of making the same

#10849
20100255129
2010-10-07

HERBAL COMPOSITION PHY906 AND ITS USE IN CHEMOTHERAPY

#10850
20100255128
2010-10-07

Avian feed composition

#10851
20100255127
2010-10-07

AROMATASE INHIBITOR

#10852
20100255126
2010-10-07

Medicament for treatment of cancer and other diseases

#10853
20100255122
2010-10-07

EDIBLE GELATIN BOWEL PREPARATION AND BOWEL CLEANSING METHOD

#10854
20100255119
2010-10-07

Mucositis Prevention Supplement and Treatment

#10855
20100255118
2010-10-07

ORAL ZINC MEDICANTS USEFUL FOR SAFELY LOWERING FREE COPPER ABSORPTION AND FREE COPPER LEVELS

#10856
20100255113
2010-10-07

HERBAL COMPOSITION FOR TREATMENT OF NEURODEGENERATION AND NEURONAL DYSFUNCTION

#10857
20100255108
2010-10-07

Combination treatment of cancer with cetuximab and tetrac

#10858
20100255088
2010-10-07

Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease

#10859
20100255078
2010-10-07

Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III

#10860
20100255077
2010-10-07

Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS

#10861
20100255069
2010-10-07

Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of , and methods of preparation thereof

#10862
20100255032
2010-10-07

Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases

#10863
20100255025
2010-10-07

Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin

#10864
20100255011
2010-10-07

Compositions and methods for modulating the activity of complement regulatory proteins on target cells

#10865
20100255009
2010-10-07

Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient

#10866
20100254990
2010-10-07

ANTI-NGF ANTIBODIES FOR THE TREATMENT OF VARIOUS DISORDERS

#10867
20100254977
2010-10-07

Engineered anti-alpha V-integrin hybrid antibodies

#10868
20100254970
2010-10-07

NGAL for reduction and amelioration of ischemic and nephrotoxic injuries

#10869
20100254968
2010-10-07

Pharmaceutical preparation for treating benign prostatic hyperplasia

#10870
20100254966
2010-10-07

TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II

#10871
20100254956
2010-10-07

Probiotic bacteria and regulation of fat storage

#10872
20100254951
2010-10-07

Nerve Regeneration Promoting Agent

#10873
20100254942
2010-10-07

HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS

#10874
20100254941
2010-10-07

INTERLEUKIN-18 BINDING PROTEINS, THEIR PREPARATION AND USE FOR THE TREATMENT OF SEPSIS

#10875
20100254940
2010-10-07

Compositions and Methods for Regulating an Immune Response in a Subject

#10876
20100254938
2010-10-07

Formulation having mobilising activity

#10877
20100254937
2010-10-07

Methods of using interleukin-1 receptor antagonist as a myeloprotective agent

#10878
20100254934
2010-10-07

Ophthalmic compositions comprising povidone-iodine

#10879
20100254919
2010-10-07

Topical Turmeric Skin Care Products

#10880
20100254916
2010-10-07

Compounds that inhibit (block) bitter taste in composition and use thereof

#10881
20100254905
2010-10-07

Inhibitors of Bruton's tyrosine kinase

#10882
20100249747
2010-09-30

Transdermal venous access locking solution

#10883
20100249746
2010-09-30

Drug delivery system for accelerated subcutaneous absorption

#10884
20100249242
2010-09-30

METHOD OF REDUCING NEURONAL CELL DAMAGE

#10885
20100249237
2010-09-30

Non-steroidal anti-inflammatory drug dosing regimen

#10886
20100249227
2010-09-30

Compositions containing zinc salts for coating medical articles

#10887
20100249222
2010-09-30

Methods of treating skin with aromatic skin-active ingredients

#10888
20100249160
2010-09-30

Cancer Treatment Method

#10889
20100249150
2010-09-30

Stable pharmaceutical composition of freeze-dried tetrodoxin powder

#10890
20100249146
2010-09-30

Heteroaryloxy quinazoline derivative

#10891
20100249136
2010-09-30

ORGANIC COMPOUNDS

#10892
20100249116
2010-09-30

Compositions and Methods for Treating Intoxications

#10893
20100249112
2010-09-30

COMBINATION OF CHK AND PARP INHIBITORS FOR THE TREATMENT OF CANCERS

#10894
20100249104
2010-09-30

Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival

#10895
20100249103
2010-09-30

COMBINATION TREATMENT

#10896
20100249090
2010-09-30

NEUROTHERAPEUTIC COMPOSITION AND METHOD THEREFOR

#10897
20100249048
2010-09-30

BETA GLYCOLIPIDS FOR THE TREATMENT OF CALCIFICATION RELATED DEGENERATIVE DISORDERS

#10898
20100249040
2010-09-30

Alpha-fetoprotein peptides and uses thereof

#10899
20100249031
2010-09-30

Nutritional Composition Comprising Curcuminoids and Methods of Manufacture

#10900
20100249030
2010-09-30

ANTI-MITOTIC AGENT AND AURORA KINASE INHIBITOR COMBINATION AS ANTI-CANCER TREATMENT

#10901
20100249028
2010-09-30

Oral composition

#10902
20100249027
2010-09-30

CRF CONJUGATES WITH EXTENDED HALF-LIVES

#10903
20100249024
2010-09-30

CETP inhibitors

#10904
20100249023
2010-09-30

ISOFLAVONE FORMULATION

#10905
20100249019
2010-09-30

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#10906
20100248376
2010-09-30

In-vitro method for testing bioequivalence of iron-sucrose formulation

#10907
20100248371
2010-09-30

Methods and compositions for modulating RAD51 and homologous recombination

#10908
20100248249
2010-09-30

Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels

#10909
20100247734
2010-09-30

Methods for making nutritional compositions comprising curcuminoids

#10910
20100247708
2010-09-30

Hop acids as a replacement for antibiotics in animal feed

#10911
20100247693
2010-09-30

COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA

#10912
20100247692
2010-09-30

Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function

#10913
20100247691
2010-09-30

Anti-angiogenic agents and anti-obesity substances applied with anti-angiogenesis from natural products

#10914
20100247689
2010-09-30

Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue

#10915
20100247687
2010-09-30

FORMULATION FOR TATTOO REMOVAL AND METHOD OF USING SAME

#10916
20100247685
2010-09-30

Methods For Treating and Reducing the Incidence of Newcastle Disease

#10917
20100247682
2010-09-30

Use of nitrite salts for the treatment of cardiovascular conditions

#10918
20100247681
2010-09-30

Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes

#10919
20100247680
2010-09-30

Compositions and Methods to Modulate Angiogenesis

#10920
20100247679
2010-09-30

METHODS AND COMPOSITIONS FOR ALTERING CELL FUNCTION

#10921
20100247676
2010-09-30

Compositions and methods for treatment of hemorrhage

#10922
20100247673
2010-09-30

Thyroid protection in sickle cell anemia treatment

#10923
20100247649
2010-09-30

PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE

#10924
20100247645
2010-09-30

PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN

#10925
20100247640
2010-09-30

Solid oral dosage form containing an enhancer

#10926
20100247635
2010-09-30

Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same

#10927
20100247634
2010-09-30

Compositions and methods for inhibiting gastric acid secretion

#10928
20100247628
2010-09-30

Skin treatment compositions containing copper-pigment complexes

#10929
20100247625
2010-09-30

Orally bioavailable lipid-based constructs

#10930
20100247622
2010-09-30

TREATMENT REGIME FOR PROLIFERATIVE DISORDERS

#10931
20100247620
2010-09-30

Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product

#10932
20100247602
2010-09-30

METHOD OF REDUCING THE EFFECTS OF CYTOSTATIC DRUGS ON BONE MARROW DERIVED CELLS, AND METHODS OF SCREENING

#10933
20100247586
2010-09-30

Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties

#10934
20100247579
2010-09-30

THERAPEUTIC AGENT FOR CANCER

#10935
20100247563
2010-09-30

Topical skin care formulations

#10936
20100247557
2010-09-30

Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 Agonist

#10937
20100247544
2010-09-30

Compositions and methods for promoting the healing of tissue of multicellular organisms

#10938
20100247540
2010-09-30

Methods and Compositions For Modulating Angiogenesis

#10939
20100247537
2010-09-30

Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide

#10940
20100247533
2010-09-30

TREATMENT WITH A HUMANIZED ANTI-EGFR IgG1 ANTIBODY AND IRINOTECAN

#10941
20100247527
2010-09-30

Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody

#10942
20100247510
2010-09-30

Thrombin-like enzyme for reducing a side effect of an anticancer drug

#10943
20100247505
2010-09-30

Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and/or C-reactive protein in blood

#10944
20100247501
2010-09-30

Foodstuff comprising an extract of a plant of the genus and flavonoid

#10945
20100247491
2010-09-30

Potentiation of Stem Cell Homing and Treatment of Organ Dysfunction or Organ Failure

#10946
20100247484
2010-09-30

COMBINATION THERAPY OF AN AFUCOSYLATED ANTIBODY AND ONE OR MORE OF THE CYTOKINES GM CSF, M CSF AND/OR IL3

#10947
20100247483
2010-09-30

Therapeutic agent composition and method of use

#10948
20100247454
2010-09-30

Compositions for elastogenesis and connective tissue treatment

#10949
20100247453
2010-09-30

COMPOSITION AND METHOD OF TREATING A SORE THROAT

#10950
20100247452
2010-09-30

USE OF ERYTHROPOIETIN

#10951
20100247451
2010-09-30

USE OF ERYTHROPOIETIN

#10952
20100247450
2010-09-30

USE OF ERYTHROPOIETIN

#10953
20100247440
2010-09-30

Mycobacterial immunotherapy for cancer treatment

#10954
20100247427
2010-09-30

Methods of inhibiting cell growth and methods of enhancing radiation responses

#10955
20100241197
2010-09-23

METHODS OF USING NITROXIDES IN CONJUNCTION WITH PHOTOSENSITIZERS AND SONOSENSITIZERS

#10956
20100240755
2010-09-23

Therapeutic and cosmetic compositions for treatment of skin

#10957
20100240745
2010-09-23

METHOD OF TREATMENT OF INFLAMMATION IN HYPERTENSIVE PATIENTS

#10958
20100240742
2010-09-23

Anti-angiogenic nanoparticle compositions

#10959
20100240741
2010-09-23

PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF APTAMERS

#10960
20100240735
2010-09-23

Compositions and methods for angiogenic therapy utilizing genes encoding ets-1

#10961
20100240721
2010-09-23

SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF

#10962
20100240697
2010-09-23

PHARMACEUTICAL COMPOSITION FOR TREATING OVERACTIVE BLADDER

#10963
20100240688
2010-09-23

1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-[1,4′] bipyridinyl-2′-ones

#10964
20100240684
2010-09-23

Minoxidil aqueous composition containing bile acid

#10965
20100240683
2010-09-23

COMBINATION THERAPY, COMPOSITION AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS

#10966
20100240645
2010-09-23

COMBINATION OF CHECKPONIT KINASE (CHK) AND TELANGIECTASIA MUTATED (ATM) INHIBITORS FOR THE TREATMENT OF CANCER

#10967
20100240628
2010-09-23

Skin treatments

#10968
20100240627
2010-09-23

COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS

#10969
20100240626
2010-09-23

Antiemetic-oral contraceptive combination

#10970
20100240621
2010-09-23

TOPICAL PHARMACEUTICAL COMPOSITION FOR THE COMBINATION OF FUSIDIC ACID AND A CORTICOSTEROID

#10971
20100240618
2010-09-23

Substituted piperazines

#10972
20100240616
2010-09-23

NOVEL LIPID COMPOUNDS

#10973
20100240607
2010-09-23

Dextrin-containing composition for preventing surgical adhesions

#10974
20100240605
2010-09-23

NOVEL IMMUNOTHERAPY STRATEGY

#10975
20100240602
2010-09-23

METHODS AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS

#10976
20100240599
2010-09-23

ANTIOXIDANT CONSTITUENTS

#10977
20100240596
2010-09-23

REPAIR OF RUPTURED MEMBRANE BY INJECTION OF NATURALLY OCCURRING PROTEIN IN AMNIOTIC FLUID SAC

#10978
20100240595
2010-09-23

Improved Antitumoral Treatments

#10979
20100240588
2010-09-23

Compound for use in the treatment of peripheral neuropathies

#10980
20100240585
2010-09-23

IN VIVO CELL SURFACE ENGINEERING

#10981
20100239695
2010-09-23

Blackberry leaf extract as an active ingredient against skin irritations and inflammations

#10982
20100239693
2010-09-23

Cannabinoid-containing plant extracts as neuroprotective agents

#10983
20100239690
2010-09-23

COMPOSITION FOR ORAL CAVITY AND SKIN

#10984
20100239689
2010-09-23

Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein

#10985
20100239682
2010-09-23

COLONIC DELIVERY OF ANTIMICROBIAL AGENTS

#10986
20100239669
2010-09-23

Combinations of statins and anti-obesity agent

#10987
20100239665
2010-09-23

PHARMACEUTICAL NIMODIPINE COMPOSITIONS

#10988
20100239652
2010-09-23

IMMUNOLIPOSOMES FOR TREATMENT OF CANCER

#10989
20100239645
2010-09-23

Methods and compositions for wound healing

#10990
20100239641
2010-09-23

Warming vapor pad

#10991
20100239634
2010-09-23

Compositions and methods for promoting bone formation

#10992
20100239608
2010-09-23

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#10993
20100239603
2010-09-23

Combinations of botanical extracts for promoting cardiovascular health

#10994
20100239576
2010-09-23

Amino ester derivatives, sailts thereof and methods of use

#10995
20100239563
2010-09-23

PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL DISEASES

#10996
20100239553
2010-09-23

Methods for promoting cellular health and treatment of cancer

#10997
20100239552
2010-09-23

Combination Therapies for Treating Metabolic Disorders

#10998
20100239534
2010-09-23

Hybrid proteins that migrate retrogradely and transynaptically into the CNS

#10999
20100239529
2010-09-23

PEG-interferon-beta formulations

#11000
20100239528
2010-09-23

Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta

#11001
20100239523
2010-09-23

TLR MODULATORS AND METHODS FOR USING THE SAME

#11002
20100239522
2010-09-23

Chemotherapeutic for inducing an MSH2-dependent apoptotic pathway

#11003
20100236550
2010-09-23

DRY-POWDER MEDICAMENT

#11004
20100234828
2010-09-16

Methods and compositions for facilitating arterial access

#11005
20100234677
2010-09-16

Reproductive management

#11006
20100234676
2010-09-16

Composition and method to modify sperm function and increase male gender ratio in mammals

#11007
20100234467
2010-09-16

METHODS FOR IMPROVING BIOAVAILABILITY OF A RENIN INHIBITOR

#11008
20100234465
2010-09-16

Administration of intravenous ibuprofen

#11009
20100234461
2010-09-16

Compositions for improved oxidative status in companion animals

#11010
20100234449
2010-09-16

Immunostimulatory method

#11011
20100234443
2010-09-16

Combinations of statins and anti-obesity agent

#11012
20100234442
2010-09-16

Compositions and Methods for Treatment and Prevention of Cardiovascular Disease

#11013
20100234426
2010-09-16

Phenylpropionamide compounds and the use thereof

#11014
20100234413
2010-09-16

COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS

#11015
20100234411
2010-09-16

New Combination for the Treatment of Respiratory Diseases

#11016
20100234408
2010-09-16

PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF NEUROFIBROMATOSIS

#11017
20100234393
2010-09-16

USE OF A VASOPEPTIDASE INHIBITOR FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

#11018
20100234382
2010-09-16

COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR

#11019
20100234368
2010-09-16

Substituted indole derivatives for the treatment of respiratory diseases

#11020
20100234354
2010-09-16

Pyridazinone derivatives

#11021
20100234349
2010-09-16

PHARMACEUTICAL COMBINATIONS OF A NICOTINE RECEPTOR MODULATOR AND A COGNITIVE ENHANCER

#11022
20100234339
2010-09-16

SILVER(I) COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT,PROPHYLAXIS AND PREVENTION OF INFECTIONS

#11023
20100234333
2010-09-16

Quinuclidine derivatives and medicinal compositions containing the same

#11024
20100234317
2010-09-16

Use of difructose anhydride-containing composition

#11025
20100234295
2010-09-16

Treating alzheimer's disease and osteoporosis and reducing aging

#11026
20100234278
2010-09-16

PROPHYLACTIC AND/OR THERAPEUTIC AGENTS FOR PERIPHERAL NEUROPATHY

#11027
20100234273
2010-09-16

Delivery of a light-activated cation channel into the brain of a subject

#11028
20100234219
2010-09-16

Isoxazolines for controlling invertebrate pests

#11029
20100233672
2010-09-16

GRAPE POLYPHENOLICS FOR PLATELET AND BACTERIAL CONTROL

#11030
20100233304
2010-09-16

COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS

#11031
20100233297
2010-09-16

SYSTEMIC ADMINISTRATION OF NAC AS AN ADJUNCT IN THE TREATMENT OF TERRORISM EXPOSURES SUCH AS RADIATION AND FOR PROPHYLAXIS

#11032
20100233294
2010-09-16

Use of tellurium compounds for inhibition of interleukin-converting enzyme

#11033
20100233291
2010-09-16

Animal lesion treatment and prevention formulations and methods

#11034
20100233290
2010-09-16

Use of difructose anhydride-containing composition

#11035
20100233284
2010-09-16

Method and composition for treatment of yeast infection through a radial appliance or a wet-cell battery appliance and solution jar set

#11036
20100233280
2010-09-16

Omega-3 enriched fish oil-in-water parenteral nutrition emulsions

#11037
20100233261
2010-09-16

Pharmaceutical Composition Comprising Amlodipine and Losartan

#11038
20100233260
2010-09-16

Pharmaceutical composition for oral administration

#11039
20100233256
2010-09-16

SYNERGISTIC COMBINATIONS FOR TREATING HYPERTENSION

#11040
20100233255
2010-09-16

Combination of triazine derivatives and insulin secretion stimulators

#11041
20100233247
2010-09-16

Dressing Material Comprising Active Substances

#11042
20100233218
2010-09-16

COMBINATION ENZYME FOR CYSTIC FIBROSIS

#11043
20100233216
2010-09-16

USE OF MICROVESICLES (MVS) FOR PREPARING A MEDICAMENT HAVING ADJUVANT ACTIVITY ON ENDOTHELIAL CELL TRANSPLANTATION, PARTICULARLY IN THE TREATMENT OF DIABETES BY PANCREATIC ISLET TRANSPLANTATION, AND RELATED METHOD

#11044
20100233198
2010-09-16

USE OF OLIGOSACCHARIDES CONTAINING N-ACETYLLACTOSAMINE FOR MATURATION OF IMMUNE RESPONSES IN NEONATES

#11045
20100233194
2010-09-16

TREATMENT OF NEOVASCULAR OCULAR DISEASE STATES

#11046
20100233193
2010-09-16

SYSTEMIC ADMINISTRATION OF NAC FOR VACCINATION PROPHYLAXIS

#11047
20100233182
2010-09-16

Antibodies against toxins and uses thereof

#11048
20100233181
2010-09-16

Antibodies against clostridium difficile toxins and uses thereof

#11049
20100233166
2010-09-16

IDO inhibitors and methods of use

#11050
20100233164
2010-09-16

Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies

#11051
20100233159
2010-09-16

Methods of treating stroke and traumatic brain injury using humanized AQC2 anti-VLA-1 antibodies

#11052
20100233158
2010-09-16

INDUCTION OF IMMUNE TOLERANCE

#11053
20100233150
2010-09-16

REDUCTION OF ADIPOSE TISSUE

#11054
20100233148
2010-09-16

Injection of fibrin sealant including an anesthetic in spinal applications

#11055
20100233145
2010-09-16

COMPOSITION USED AS A NUTRITIONAL SUPPLEMENT AND MEDICATION FOR THE TREATMENT OF DEGENERATIVE VISUAL DISORDERS AND INFLAMMATION

#11056
20100233129
2010-09-16

PREVENTION AND TREATMENT OF SECONDARY INFECTIONS FOLLOWING VIRAL INFECTION

#11057
20100233128
2010-09-16

Natural Skin Products Containing Dairy and Processes

#11058
20100233121
2010-09-16

METHOD FOR TREATING MULTIPLE SCLEROSIS

#11059
20100233119
2010-09-16

Suppression of immune response to factor VIII in hemophilia A patients

#11060
20100233118
2010-09-16

Use of WF10 for treating allergic asthma, allergic rhinitis and atopic dermatitis

#11061
20100233111
2010-09-16

GASTROPOD BIOLOGICAL FLUID, METHOD OF MAKING AND REFINING AND USE

#11062
20100233109
2010-09-16

Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists

#11063
20100233081
2010-09-16

Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs

#11064
20100230203
2010-09-16

Energy absorbing thermoplastic elastomer

#11065
20100229281
2010-09-16

Elastomeric gloves and methods of making

#11066
20100228183
2010-09-09

METHOD AND APPARATUS FOR THE DEACTIVATION OF BACTERIAL AND FUNGAL TOXINS IN WOUNDS, AND FOR THE DISRUPTION OF WOUND BIOFILMS

#11067
20100227936
2010-09-09

Treatment of microbial infections with compounds that inhibit 4-hydroxyphenylpyruvate dioxygenase

#11068
20100227929
2010-09-09

Transdermal compositions

#11069
20100227928
2010-09-09

Non-steroidal anti-inflammatory ophthalmic compositions

#11070
20100227895
2010-09-09

METHOD FOR TREATING EQUINE LAMINITIS

#11071
20100227886
2010-09-09

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#11072
20100227885
2010-09-09

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#11073
20100227876
2010-09-09

Methods of Reducing Side Effects of Analgesics

#11074
20100227867
2010-09-09

Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

#11075
20100227864
2010-09-09

5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same

#11076
20100227854
2010-09-09

Oral Pharmaceutical Formulations Containing Non-Steroidal Anti-Inflammatory Drugs and Acid Inhibitors

#11077
20100227852
2010-09-09

Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors

#11078
20100227850
2010-09-09

METHODS FOR PREVENTING AND TREATING MICROBIAL INFECTIONS BY MODULATING TRANSCRIPTION FACTORS

#11079
20100227844
2010-09-09

CANNABINOID-1 RECEPTOR MODULATORS USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#11080
20100227832
2010-09-09

Modulation of telomere length in telomerase positive cells and cancer therapy

#11081
20100227828
2010-09-09

Synergistic phytochemical composition for the treatment of obesity

#11082
20100227801
2010-09-09

PHARMACEUTICAL COMPOSITIONS

#11083
20100227799
2010-09-09

SIMULTANEOUS PHOTODYNAMIC THERAPY AND PHOTO INDUCED POLYMERIZATION

#11084
20100227798
2010-09-09

USE OF THE STAUDINGER LIGATION IN IN VIVO ASSEMBLY OF A BIOLOGICALLY ACTIVE COMPOUND

#11085
20100227792
2010-09-09

Phospholipid and protein tablets

#11086
20100227791
2010-09-09

Compounds having antitumor activity

#11087
20100227774
2010-09-09

Method For Generating and Selecting Antibodies Against Target Protein

#11088
20100227006
2010-09-09

Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

#11089
20100227003
2010-09-09

Self-Preserving Compositions

#11090
20100227002
2010-09-09

Antioxidant compositions comprising extracts of myrtle and rosemary

#11091
20100227001
2010-09-09

METHOD OF DELIVERING NUTRIENTS

#11092
20100226998
2010-09-09

ANTI-VIRAL AND ANTI-MICROBIAL DENTAL OPERATIVE MATERIAL AND METHODS

#11093
20100226996
2010-09-09

Compositions and methods of delivery of pharmacological agents

#11094
20100226980
2010-09-09

NOVEL TABLET BASED ON S-ADENOSYL-METHIONINE

#11095
20100226972
2010-09-09

TRANSDERMAL PAIN GEL

#11096
20100226968
2010-09-09

Topical agent for muscle treatment

#11097
20100226936
2010-09-09

Plant extract compositions for prevention and treatment of influenza

#11098
20100226922
2010-09-09

SPECIFIC PROTEASE INHIBITORS AND THEIR USE IN CANCER THERAPY

#11099
20100226919
2010-09-09

Antitumoral Treatments

#11100
20100226917
2010-09-09

METHODS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES